Institute of Informatics, University of Warsaw, ul. Banacha 2, Warsaw, Poland.
J Theor Biol. 2012 Sep 21;309:34-46. doi: 10.1016/j.jtbi.2012.04.031. Epub 2012 Jun 5.
JAK-STAT pathway family is a principal signaling mechanism in eukaryotic cells. Evolutionary conserved roles of this mechanism include control over fundamental processes such as cell growth or apoptosis. Deregulation of the JAK-STAT signaling is frequently associated with cancerogenesis. JAK-STAT pathways become hyper-activated in many human tumors. Therefore, components of these pathways are an attractive target for drugs, which design requires as adequate models as possible. Although, in principle, JAK-STAT signaling is relatively simple, the ambiguities in a receptor activation prevent a clear explanation of the underlying molecular mechanism. Here, we compare four variants of a computational model of the JAK1/2-STAT1 signaling pathway. These variants capture known, basic discrepancies in the mechanism of activation of a cytokine receptor, in the context of all key components of the pathway. We carry out a comparative analysis using mass action kinetics. The investigated differences are so marginal that all models satisfy a goodness of fit criteria to the extent that the state of the art Bayesian model selection (BMS) method fails to significantly promote one model. Therefore, we comparatively investigate changes in a robustness of the JAK1/2-STAT1 pathway variants using the global sensitivity analysis method (GSA), complemented with the identifiability analysis (IA). Both BMS and GSA are used to analyze the models for the varying parameter values. We found out that, both BMS and GSA, narrowed down to the receptor activation component, slightly promote the least complex model. Further, insightful, comprehensive GSA, motivated by the concept of robustness, allowed us to show that the precise order of reactions of a ligand binding and a receptor dimerization is not as important as the on-membrane pre-assembly of the dimers in the absence of ligand. The main value of this work is an evaluation of the usefulness of different model selection methods in a frequently encountered, but not much discussed case of a model of a considerable size, which has several variants differing at peripheries. In such situation, all considered variants can reach nearly perfect agreement with respect to their numerical simulations results and, most often, the sufficient experimental data to test against is not available. We argue that in such an adverse setting, the GSA and IA, although not directly corresponding to the model selection problem, can be more informative than the representative, generalizability-based approaches to this task. An additional insight into how the responsibility for the network dynamics spreads among model parameters, enables more conscious, expert-mediated choice of the preferred model.
JAK-STAT 通路家族是真核细胞中主要的信号转导机制。该机制的进化保守作用包括控制细胞生长或凋亡等基本过程。JAK-STAT 信号的失调经常与癌症发生有关。JAK-STAT 通路在许多人类肿瘤中过度激活。因此,这些通路的成分是药物设计的一个有吸引力的靶点,这需要尽可能好的模型。尽管 JAK-STAT 信号在原则上相对简单,但受体激活的不明确性阻止了对潜在分子机制的清晰解释。在这里,我们比较了 JAK1/2-STAT1 信号通路的四种计算模型变体。这些变体捕获了细胞因子受体激活机制中的已知基本差异,同时考虑了通路的所有关键成分。我们使用质量作用动力学进行了比较分析。研究的差异非常微小,以至于所有模型都满足拟合度标准,以至于最先进的贝叶斯模型选择 (BMS) 方法无法显著促进一个模型。因此,我们使用全局敏感性分析方法 (GSA) 比较研究了 JAK1/2-STAT1 通路变体的稳健性变化,并辅以可识别性分析 (IA)。BMS 和 GSA 都用于分析模型的变化参数值。我们发现,BMS 和 GSA 都缩小到受体激活组件,稍微促进最简单的模型。此外,深入的、全面的 GSA,由稳健性的概念驱动,使我们能够表明,配体结合和受体二聚化的反应顺序并不像在没有配体的情况下,二聚体在膜上的预组装那样重要。这项工作的主要价值是评估不同模型选择方法在一种经常遇到但讨论不多的情况下的有用性,即模型尺寸相当大,并且有几个变体在边缘处不同。在这种情况下,所有考虑的变体都可以在其数值模拟结果方面达到几乎完美的一致,并且通常情况下,没有足够的实验数据来进行测试。我们认为,在这种不利的情况下,尽管 GSA 和 IA 与模型选择问题没有直接对应,但与代表性的、基于通用性的方法相比,它们可以提供更多的信息。对网络动态的责任如何在模型参数之间传播的深入了解,可以使更有意识、更专业的选择首选模型成为可能。